Nuvaring Pulmonary Embolism and Deep Vein Thrombosis Risks

Posted by Shezad Malik MD JDMay 30, 2012 1:09 PM

According to medical experts, NuvaRing (etonogestrel/ethinyl estradiol vaginal ring) users are prone to serious and life-threatening NuvaRing blood clots, known as venous thromboembolism, and other dangerous NuvaRing side effects.

Recently medical studies, by the U.S. Food & Drug Administration (FDA) and the British Medical Journal, have found that NuvaRing raises the risk of deadly blood clots. The studies demonstrated that NuvaRing increased deep vein thrombosis and pulmonary embolism, when compared to older hormonal birth control pills.

NuvaRing side effects include:

Deep vein thrombosis Pulmonary embolism Heart attacks Strokes Wrongful death

What is NuvaRing?

NuvaRing is a hormonal contraceptive device that releases a combination of etonogestrel, a synthetic third generation progestin, and the estrogen, ethinyl estradiol.

Merck & Co.s Organon subsidiary, released NuvaRing in 2001. NuvaRing is a small flexible ring that is designed to be inserted into the vagina once a month. NuvaRing prevents pregnancy by releasing controlled amounts of those hormones into the bloodstream.

FDA October 2011 Study

Continued here:
Nuvaring Pulmonary Embolism and Deep Vein Thrombosis Risks